Ulster University and Randox Laboratories Ltd have launched a £5 million skills development initiative to support up to ten individuals annually through PhD level study in the Life Sciences sector.
The Randox-Ulster University-Industrial PhD Academy, which aims to encourage the development of advanced, higher level skills in key industry sectors, will further reinforce Ulster University’s position as one of the top universities for biomedical related research impact and, enhance Randox’s competitiveness in the growing global healthcare sector.
Up to ten PhD researchers will be supported annually, including Randox employees and individuals from the wider sector, who are working on a range of scientific projects, with the ultimate goal of new product development. They will have the opportunity to work on new research projects, driven by industry and jointly supervised by Ulster University and Randox, to enhance their own individual skill sets whilst delivering groundbreaking advances in the life sciences sector. Ulster University and Randox will each fully fund up to five PhD researchers annually.
To date PhD researchers enrolled in this new programme of Industrial Research have started exciting projects in areas of medicine including mental health, diabetes and cancer, with more projects being developed. All projects share the common goal of delivering new diagnostic approaches for early detection of disease and earlier intervention where possible.
Professor Alastair Adair Deputy Vice-Chancellor Ulster University said:
“Ulster University is renowned globally for research in personalised medicine, cancer, diabetes and mental health and this makes us the perfect fit for a global industry leader like Randox. Ulster University and Randox have a longstanding partnership built around research, knowledge sharing and collaboration which has placed both organisations at the forefront of diagnostics and health research globally.”
